Validation of French Version of LCADL and Dyspnea-12

Completed

• Conditions: Copd

• Registration Number: NCT02555202
• Lead Sponsor: University Hospital, Brest

Brief Summary

The main objective of this study is to develop and to validate a French version of the London Chest Activity of Daily Living (LCADL) and the Dyspnea 12 and to determine the reliability of this version for the evaluation of the dyspnea in the Activity of Daily Living in COPD patients (stages severe and very severe).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2015-09-16
• Study First Submitted QC: 2015-09-18
• Study First Posted: 2015-09-21
• Study Start: 2015-10-15
• Status Verified: 2016-09
• Primary Completion: 2016-09-30
• Study Completion: 2016-09-30
• Last Update Submitted: 2017-03-30
• Last Update Posted: 2017-03-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• COPD with FEV1< 50% of predictive value

Exclusion Criteria

• FEV1> 50% of predictive value
• Patients with an exacerbation of COPD in the previous 30 days the inclusion

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the Saint-Georges questionnaire, item Activity	15 days	by comparison with item activities of the Saint-Georges questionnaire for the LCADL
MMRC Dyspnea scale	15 days	by comparison with MMRC dyspnea scale for the dyspnea 12

Trial Locations

Locations (1)

Brest University hospital; 🇫🇷 Morlaix, France